Back to company

Novo Nordisk Denmark A/S: Financial statements 2020

CVR: 38180045

Novo Nordisk Denmark A/S (CVR 38180045) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 330,145,351 and a net result of DKK 21,277,960 compared with DKK 5,251,810 the year before. That is a decrease of 9.3% compared with the year before. The profit margin was 6.4%. Equity amounted to DKK 36,587,365. The solvency ratio was 6.3%. The company had 152 employees in the financial year.

Revenue
330,145,351 kr.
Gross Profit
276,132,396 kr.
Profit/Loss
21,277,960 kr.
Equity
36,587,365 kr.
Total Assets
584,971,435 kr.
Employees
152

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020330.1 mio.276.1 mio.21.3 mio.36.6 mio.152
2019363.9 mio.134.9 mio.5.3 mio.15.3 mio.65
2018341.9 mio.119.2 mio.4.2 mio.10.1 mio.69

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Novo Nordisk Denmark A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Novo Nordisk Denmark A/S: The 2019 annual report is outJun 3, 2020

Novo Nordisk Denmark A/S has published its annual report for 2019. Revenue came to DKK 363,935,809, and the net result was DKK 5,251,810.

Frederik Kier joins the board of Novo Nordisk Denmark A/SApr 1, 2020

As of April 1, 2020, Frederik Kier has joined the board of directors of Novo Nordisk Denmark A/S.

Morten Berger Engelund joins the board of Novo Nordisk Denmark A/SApr 1, 2020

As of April 1, 2020, Morten Berger Engelund has joined the board of directors of Novo Nordisk Denmark A/S.

Mads Veggerby Lausten leaves the board of Novo Nordisk Denmark A/SApr 1, 2020

As of April 1, 2020, Mads Veggerby Lausten has left the board of directors of Novo Nordisk Denmark A/S.

Matt Joseph Regan leaves the board of Novo Nordisk Denmark A/SApr 1, 2020

As of April 1, 2020, Matt Joseph Regan has left the board of directors of Novo Nordisk Denmark A/S.

About Novo Nordisk Denmark A/S

Novo Nordisk Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Novo Nordisk Region Europe Pharmaceuticals A/S. The management consists of Mads Wilhelm Øckenholt Larsen. The company is owned by NOVO NORDISK REGION EUROPE A/S. The company has 81 employees. In 2025, the company reported revenue of DKK 2,504,841,000 and a net result of DKK 118,803,000 compared with DKK 86,129,000 the year before. Equity amounted to DKK 134,570,000.

Other financial years